United States - English - NLM (National Library of Medicine)

lacorium health international pty ltd - tolnaftate (unii: 06kb629tkv) (tolnaftate - unii:06kb629tkv) - antifungal - clinically proven to prevent athlete's foot (tinea pedis) and ringworm (tinea corporis) with daily use - for effective relief of symptoms of athlete's foot, including itching, burning, cracking, scaling and discomfort associated with this condition.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

a. menarini singapore pte. ltd. - magnesium hydroxide; simethicone; sodium polyhydroxyaluminium mono-carbonate hexitol complex -

Australia - English - Department of Health (Therapeutic Goods Administration)

alexion pharmaceuticals australasia pty ltd - asfotase alfa, quantity: 40 mg/ml - injection, solution - excipient ingredients: sodium chloride; dibasic sodium phosphate heptahydrate; water for injections; monobasic sodium phosphate monohydrate - strensiq (asfotase alfa, rch) is indicated as enzyme replacement therapy in patients with paediatric-onset hypophosphatasia.

Australia - English - Department of Health (Therapeutic Goods Administration)

alexion pharmaceuticals australasia pty ltd - asfotase alfa, quantity: 40 mg/ml - injection, solution - excipient ingredients: sodium chloride; dibasic sodium phosphate heptahydrate; water for injections; monobasic sodium phosphate monohydrate - strensiq (asfotase alfa, rch) is indicated as enzyme replacement therapy in patients with paediatric-onset hypophosphatasia.

Australia - English - Department of Health (Therapeutic Goods Administration)

alexion pharmaceuticals australasia pty ltd - asfotase alfa, quantity: 40 mg/ml - injection, solution - excipient ingredients: sodium chloride; dibasic sodium phosphate heptahydrate; water for injections; monobasic sodium phosphate monohydrate - strensiq (asfotase alfa, rch) is indicated as enzyme replacement therapy in patients with paediatric-onset hypophosphatasia.

Australia - English - Department of Health (Therapeutic Goods Administration)

alexion pharmaceuticals australasia pty ltd - asfotase alfa, quantity: 40 mg/ml - injection, solution - excipient ingredients: sodium chloride; dibasic sodium phosphate heptahydrate; water for injections; monobasic sodium phosphate monohydrate - strensiq (asfotase alfa, rch) is indicated as enzyme replacement therapy in patients with paediatric-onset hypophosphatasia.

Australia - English - Department of Health (Therapeutic Goods Administration)

alexion pharmaceuticals australasia pty ltd - asfotase alfa, quantity: 100 mg/ml - injection, solution - excipient ingredients: dibasic sodium phosphate heptahydrate; sodium chloride; monobasic sodium phosphate monohydrate; water for injections - strensiq (asfotase alfa, rch) is indicated as enzyme replacement therapy in patients with paediatric-onset hypophosphatasia.

Peru - Spanish - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

inretail pharma s.a. - diclofenaco dietilamina; - gel - por sachet 100.00 g - diclofenaco

United States - English - NLM (National Library of Medicine)

lacorium health international pty ltd - undecylenic acid (unii: k3d86kj24n) (undecylenic acid - unii:k3d86kj24n) - undecylenic acid 250 mg in 1 ml - antifungal for the treatment of: most athlete's foot (tinea pedis), ringworm (tinea corporis). for relief of: itching, scaling, cracking, burning, redness, soreness, irritation and discomfort which may accompany these conditions.

United States - English - NLM (National Library of Medicine)

lacorium health usa inc. - oatmeal (unii: 8pi54v663y) (oatmeal - unii:8pi54v663y) - skin protectant temporarily protects and helps relieve minor skin irritation and itching due to: - rashes - eczema - poison ivy, oak or sumac - insect bites